Vanda Pharmaceuticals, Inc. (VNDA)
6.73
+0.67
(+11.06%)
USD |
NASDAQ |
Dec 10, 16:00
6.76
+0.03
(+0.45%)
After-Hours: 18:42
Vanda Pharmaceuticals Research and Development Expense (Quarterly): 22.56M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 87.83M |
| ADMA Biologics, Inc. | 1.528M |
| Aldeyra Therapeutics, Inc. | 5.431M |
| Exelixis, Inc. | 199.16M |
| Anavex Life Sciences Corp. | 7.295M |